AIDS 2010 follow-up protection: Global HIV/AIDS funding.

Regular vaccines are made to prevent attacks, but so far none has worked for HIV, the news program writes. Therapeutic vaccines, on the other hand, aim to treat infected people – in the entire case of HIV, by boosting ravaged immune systems. Related StoriesNew study finds high prevalence of HIV among pregnant refugee women in OntarioStudy evaluates effectiveness of antiretroviral treatment in HIV-infected childrenGenvoya approved as total regimen for HIV treatmentThe content examines the potential advantages a therapeutic vaccine could have over current HIV/AIDS treatments and information several approaches companies are acquiring towards the advancement of therapeutic vaccines. All of the vaccines, which were developed by several small biotechnology companies, modestly but significantly reduced viral amounts in the blood of patients, who responded for weeks or longer, the news headlines service writes.All privileges reserved. Neither of these ongoing parties endorse or recommend any commercial products, services, or equipment.

Helps Vaccine Advocacy Coalition receives $14 million from Gates Foundation The Helps Vaccine Advocacy Coalition announced today at the AIDS Vaccine 2007 Meeting that it has received a five-year, $14 million grant from the Expenses & Melinda Gates Basis to create a fresh international HIV Prevention Analysis Advocacy Network. The Advocacy Network will continue to work with civil society, policymakers, and research companions around the global globe to advance ethical analysis and development of new HIV prevention interventions, ensure that communities are educated about and involved in prevention research, and ensure that the benefits of analysis are shared globally.